| KARAMANIDOU, Ch., L. SCARFÓ, Michael DOUBEK, S. GARANI-PAPADATOS, Jana DIDI, Ch. PONTIKOGLOU, E. KAZANTZAKI, J. LING, C. PAIN, H. PAPADAKI, R. ROSENQUIST, N. STAVROYIANNI, S. PAYNE, P. GHIA, K. STAMATOPOULOS a P. NATSIAVAS. Lessons learned from MyPal digital health intervention: capitalizing on the patient reported outcomes (PRO) paradigm towards a participatory healthcare for patients with hematological malignancies. In EHA 2022 in HemaSphere 2022; 6(S3): 4028-4029. 2022. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{2211820,
author = {Karamanidou, Ch. and Scarfó, L. and Doubek, Michael and GaraniandPapadatos, S. and Didi, Jana and Pontikoglou, Ch. and Kazantzaki, E. and Ling, J. and Pain, C. and Papadaki, H. and Rosenquist, R. and Stavroyianni, N. and Payne, S. and Ghia, P. and Stamatopoulos, K. and Natsiavas, P.},
booktitle = {EHA 2022 in HemaSphere 2022; 6(S3): 4028-4029},
title = {Lessons learned from MyPal digital health intervention: capitalizing on the patient reported outcomes (PRO) paradigm towards a participatory healthcare for patients with hematological malignancies},
year = {2022}
}
TY - CONF
ID - 2211820
AU - Karamanidou, Ch. - Scarfó, L. - Doubek, Michael - Garani-Papadatos, S. - Didi, Jana - Pontikoglou, Ch. - Kazantzaki, E. - Ling, J. - Pain, C. - Papadaki, H. - Rosenquist, R. - Stavroyianni, N. - Payne, S. - Ghia, P. - Stamatopoulos, K. - Natsiavas, P.
PY - 2022
TI - Lessons learned from MyPal digital health intervention: capitalizing on the patient reported outcomes (PRO) paradigm towards a participatory healthcare for patients with hematological malignancies
ER -
KARAMANIDOU, Ch., L. SCARFÓ, Michael DOUBEK, S. GARANI-PAPADATOS, Jana DIDI, Ch. PONTIKOGLOU, E. KAZANTZAKI, J. LING, C. PAIN, H. PAPADAKI, R. ROSENQUIST, N. STAVROYIANNI, S. PAYNE, P. GHIA, K. STAMATOPOULOS a P. NATSIAVAS. Lessons learned from MyPal digital health intervention: capitalizing on the patient reported outcomes (PRO) paradigm towards a participatory healthcare for patients with hematological malignancies. In \textit{EHA 2022 in HemaSphere 2022; 6(S3): 4028-4029}. 2022.
|
